Latest NewsJun 18, 2025HiFiBiO Therapeutics to Present Preclinical Data of Three Leading I&I Programs at the 2025 Annual Meeting of the Federation of Clinical Immunology SocietiesAll Filter By: Year20252024202320222021202020192018201720162015Aug 28, 2023Fierce Biotech Names HiFiBiO Therapeutics a “Fierce 15” Biotech Company of 2023Jun 28, 2023Robert Andtbacka, MD, CM joins HiFiBiO Therapeutics as Chief Medical OfficerJun 23, 2023HiFiBiO Therapeutics Announces First Patient First Visit for the Evaluation of HFB200301 in Combination with Tislelizumab in Patients with DIS® Selected Advanced Solid TumorsBiotech2050 | Podcast | Jun 14, 2023HiFiBiO Therapeutics CEO Liang Schweizer Shares Her Professional Journey and the Company’s Pioneering DIS® Approach on the Biotech2050 PodcastApr 7, 2023HiFiBiO Therapeutics Announces Oral Presentation at 2023 American Association for Cancer Research (AACR) Annual Meeting< 1 2 3 4 5 6 … 17 >
